Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambulatory peritoneal dialysis patient.
Tokunaga
M
M
Tamura
M
M
Kabashima
N
N
Serino
R
R
Shibata
T
T
Matsumoto
M
M
Miyamoto
T
T
Miyazaki
M
M
Furuno
Y
Y
Takeuchi
M
M
Abe
H
H
Okazaki
M
M
Otsuji
Y
Y
D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014807:Vitamin D / Q000627:therapeutic use*; D005466:Fluorocarbons
D002117:Calcitriol; D014807:Vitamin D; C040488:26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3; D005466:Fluorocarbons